Delivering Breast Cancer Research To Community Oncology Teams
Download PDF
Targeted messaging & customized non-personal promotions helped a brand share key educational information and research with diverse community-based oncology prescribers and treatment influencers
OUR TASK
A leading biopharma company wanted to accelerate growth for an established brand by sharing recent research in different ways and among a diverse set of community-based stakeholders. The result: continuous improvement in engagement from predefined HCP segments—especially from oncology pharmacists—in sharing information from key opinion leaders and understanding new treatment approaches through practical applications as explained by their peers.
Download PDF
The Power of This Partnership
24%
Digital engagement with key content
The Ask
CLIENT
U.S.
Large BioPharma
Deliver Key Scientific Information
Ensure continued success in a competitive breast cancer treatment market by reinforcing appropriate patient characteristics for treating patients with early hormone receptor (HR)-positive/HER2-negative breast cancer.
Ensure Best Practice Treatment Protocols
Influence physicians by sharing relevant research and practical learnings in ways and through channels that are relevant to nurses, oncology navigators, and pharmacists.
Keep Community Practitioners Up-To-Date
Make sure key efficacy and safety findings from recent phase 3 studies for treating HR-positive/HER2-negative breast cancer, and for previously treated chronic lymphocytic leukemia and small lymphocytic lymphoma, move outside of academic medical centers.
The Approach
TOOLS
Omnichannel Strategy
Create Omnichannel Content
Enhance clinical knowledge and address practical challenges encountered in real-world settings by using the Case-Based Exchange format to deliver real-world, patient-centric scenarios to help HCPs apply new breast cancer treatment protocols.
Make Key Opinion Leaders More Accessible
Create approachable information by using the Interview with the Innovators format to summarize expert insights from thought leaders on the latest advancements in breast cancer treatment.
Improve Healthcare Outcomes at Home
Reinforce best-in-class treatments using Clinical Trials to Clinical Practice videos and webinars to emphasize key phase 3 trial results by translating research into actionable practices.
The Results
OUTCOME
Business Objectives Exceeded
Targeted Message Delivery
By aligning with trusted content sources, our client delivered 42,864 emails to HCPs who already rely on the Journal of Oncology Nursing Services (JONS), the Journal of Hematology Oncology Practice (JHOP), and Oncology Practice Management (OPM) for valuable oncology information.
Data-Driven Marketing Decisions
After analyzing past readership trends and behaviors, our client’s emails achieved a combined unique open rate of 23.63% across 2 different campaign waves—1 in late September 2025 and 1 in early October 2025.
Continuous Messaging Improvements
By analyzing results from wave 1, Amplity Comms’ content and digital specialists implemented strategic adjustments that led to a 13.65% increase in email open rates in wave 2. Additionally, click-to-open rates among JHOP audiences improved 66% in wave 2.
Delighting BioPharma Marketing Leaders
Our client saw improved HCP engagement and clinical practice educational awareness, thanks to Amplity’s ability to effectively target the right audiences with the right messages. Their strategic goals advanced more quickly than originally anticipated, and as a result, the client is currently working on additional custom solutions that will be deployed in the coming 12 months.
